Recently, three A-share listed companies—Jiuan Medical, Korrun, and By-health—have successively disclosed their indirect investments in DeepSeek. Leveraging shareholding ratios and investment sums, the market projects DeepSeek's post-money valuation, following its initial round of financing, to hover around RMB 325 billion to RMB 350.9 billion, a figure that resonates with prior speculations. As per Korrun's announcement, its wholly-owned subsidiary indirectly owns approximately 0.0114% of DeepSeek's equity, pointing towards a valuation of about RMB 350.877 billion. In its announcement, By-health revealed that it indirectly holds a 0.04% stake in DeepSeek, indicating a valuation in the ballpark of RMB 325 billion.
